Sign in

CIK 0001377121 · Large accelerated filer

Protagonist Therapeutics, Inc

Sign in to watch
Ticker
PTGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
980505495
Phone
(510) 474-0170
Business address
7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
Former names
Protagonist Therapeutics Inc, Protagonist Inc
  1. 4 Grant or award EVP Clinical Operations acquired 7,500 shares (grant or award)
  2. SC 13G/A Stake Amended Statement of Ownership
  3. SC 13G/A Stake Amended Statement of Ownership
  4. SC 13G/A Stake Amended Statement of Ownership
  5. SC 13G/A Stake Amended Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G/A Stake Amended Statement of Ownership
  8. 4 Open-market sale President and CEO sold 10,909 shares at an average $7.74 ($84,410)
  9. 4 Open-market sale Chief Scientific Officer sold 3,821 shares at $7.74 ($29,562)
  10. 4 Open-market sale Chief Medical Officer sold 2,778 shares at an average $7.74 ($21,506)
  11. SC 13G/A Stake Amended Statement of Ownership
  12. SC 13G/A Stake Amended Statement of Ownership
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Option exercise President and CEO acquired 22,344 shares (option exercise)
  16. 3 Insider Initial Statement of Ownership
  17. 8-K Event Material agreement · Unregistered share sale · Executive or director change
  18. SC 13G Stake Amended Statement of Ownership
  19. 8-K Event Regulation FD disclosure
  20. 10-Q Report Quarterly Report

Page 26 of 36 · 707 filings